Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00179335
Status:
COMPLETED
Last Update Posted:
2021-04-26
First Post:
2005-09-10
Brief Title:
Comparative Pharmacokinetics PK Study of Efavirenz or LopinavirRitonavir Between Older and Younger HIV-Infected Adults
Sponsor:
Organization:
Albert Einstein College of Medicine
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Residual plasma left from measurement of drug levels
Enrollment Count:
45
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 995 |
Who Masked List: